Hyperkalemia, self-medication, and over-the-counter drug usage in patients with cardiovascular disease in the perspective of polypragmasy

1 Stăcescu S, Hancu G, Gagyi L, Soare R, Kelemen H. Simultaneous determination of hydrochlorothiazide and telmisartan from pharmaceutical preparations using capillary electrophoresis. Studia UBB Chemia. 2017; 52(2):189-198. Search in Google Scholar

2 Korhonen P, Vesalainen R, Aarnio P, Kautiainen H, Järvenpää S, Kantola I. Assessment of cardiovascular risk in primary health care. Scand J Prim Health Care. 2012; 30:101-106. Search in Google Scholar

3 Dorobantu M, Tautu OF, Darabont R, et al. Objectives and methodology of Romanian SEPHAR II Survey. Project for comparing the prevalence and control of cardiovascular risk factors in two East-European countries: Romania and Poland. Arch Med Sci. 2015; 11(4):715-723. Search in Google Scholar

4 Massimo FP, Hoes AW, Agewall S, et al. 2016 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 2016; 37: 2315–2381. Search in Google Scholar

5 Dorobantu M, Bartos D, Apetrei E, et al. Hypertension in Romania: Where are we and what can we do? Results from SEPHAR II study. Rom J Cardiol. 2012; 22(4):285-290. Search in Google Scholar

6 Bálint I, Nemes-Nagy E, Csibi M, et al. The role of diet and lifestyle habits in prevention of cardiovascular diseases in Moldavian and Transylvanian population. Rev Chim. 2017; 68:1460-1465. Search in Google Scholar

7 Hilary J, Gallagher PF, O’Mahony D. Inappropriate prescribing and adverse drug events in older people. BMC Geriatrics. 2009; 9(1):1-4. Search in Google Scholar

8 Hyon KC, Soriano LC, Zhang Y, Rodriguez LAG. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ. 2012; 344:81-90. Search in Google Scholar

9 Dent A, Walmsley D, Dhandapani S. Hyperkalemia is a risk with low sodium salt in vulnerable patients. BMJ. 2011; 343:4514. Search in Google Scholar

10 Amir O, Hassan Y, Sarriff A, Awaisu A, Abd Aziz N, Ismail O. Incidence of risk factors for developing hyperkalemia when using ACE inhibitors in cardiovascular diseases. Pharm World Sci. 2009; 31:387-393. Search in Google Scholar

11 Manns B, Hemmelgarn B, Tonelli M, et al. Population based screening for chronic kidney disease: cost effectiveness study. BMJ. 2010; 341:c5869. Search in Google Scholar

12 Cruz CS, Cruz AA, Marcílio de Souza CA. Hyperkalemia in congestive heart failure patients using ACEI and spironolactone. Nephrol Dial Transplant. 2003; 18:1814-1819. Search in Google Scholar

13 Montalescot G, Collet JP. Preserving cardiac function in the hypertensive patient: Why renal parameters hold the key. Eur Heart J. 2005; 26(24):2616-2622. Search in Google Scholar

14 Ochodnicky P, Henning RH, Van Dokkum RPE, De Zeeuw D. Microalbuminuria and endothelial dysfunction: Emerging targets for primary prevention of end-organ damage. J Cardiovasc Pharmacol. 2006; 47:S151-S162. Search in Google Scholar

15 Donnelly R, Yeung JMC, Manning G. Microalbuminuria: A common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes. J Hypertens. 2003; 21(suppl 1): S7-S12. Search in Google Scholar

16 Holmes HM, Luo R, Hanlon JT, Elting LS, Suarez-Almazor M, Goodwin JS. Ethnic disparities in adherence to antihypertensive medications of medicare part D beneficiaries. J Am Geriatr Soc. 2012; 60(7):1298-1303. Search in Google Scholar

17 Fogarasi E, Croitoru MD, Fülöp I, et al. Malondialdehyde levels can be measured in serum and saliva by using a fast HPLC method with visible detection; Rev Rom Med Lab; 2016; 24(3):319-326. Search in Google Scholar

18 Tarcea M, Fazakas Z, Szucs V, et al. Mean Dietary Fiber Intake of Romanian Adults Results of a Survey Questionnaire. Rev Chim. 2017; 68(9):2083-2087. Search in Google Scholar

19 Floege J, Johnson RJ, Feehally J. Comprehensive Clinical Nephrology. 4th ed. Philadelphia, PA. Saunders Elsevier. 2010;118-129. Search in Google Scholar

20 Guyton AC, Hall JE (eds). Unit V: The Body Fluids and Kidneys in Textbook of Medical Physiology. 11th Edition. Elsevier. Philadelphia, PA. 2005. Search in Google Scholar

21 Lieberman M, Marks AD (eds). Mark’s Basic Medical Biochemistry A Clinical Approach. 3rd Ed. Lippincott Williams & Wilkins. Philadelphia, PA. 2009. Search in Google Scholar

22 Ray K, Dorman S, Watson R.: Severe hyperkalaemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: a potentially life-threatening interaction. J Hum Hypertens. 1999; 13:717-20. Search in Google Scholar